Research indicates that variables like bulky disease and Ki67 are strong independent predictors of how long a patient will remain in remission.
💡 The inclusion of the P4 (Interim PET) parameter is significant because it allows doctors to adjust treatment mid-course based on how the tumor is actually responding to chemotherapy. Clinical Significance Research indicates that variables like bulky disease and
High KBMP4 scores often signal that standard R-CHOP therapy may not be enough, potentially leading to more intensive consolidative strategies or clinical trials. Research indicates that variables like bulky disease and